These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 22629714)

  • 1. [Endotoxin (LPS) in the pathogenesis of atherosclerosis].
    Konev IuV; Lazebnik LB
    Eksp Klin Gastroenterol; 2011; (11):15-26. PubMed ID: 22629714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR4 antagonist reduces early-stage atherosclerosis in diabetic apolipoprotein E-deficient mice.
    Lu Z; Zhang X; Li Y; Jin J; Huang Y
    J Endocrinol; 2013 Jan; 216(1):61-71. PubMed ID: 23060524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes.
    Lu Z; Zhang X; Li Y; Lopes-Virella MF; Huang Y
    Immunobiology; 2015 Nov; 220(11):1246-54. PubMed ID: 26162692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative analysis of individual groups of microorganisms, extracted from atherosclerotic lesions in the coronary arteries in patients depending upon ASP299GLY polymorphism of TLR4 gene].
    Skochko OV; Vesnina LÉ; Bobrova NA; Shlykova OA; Mamontova TV; Izmaĭlova OV; Kaĭdashev IP
    Lik Sprava; 2012; (3-4):82-6. PubMed ID: 23356143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The receptor theory of atherosclerosis].
    Likhoded VG; Bondarenko VM; Gintsburg AL
    Vestn Ross Akad Med Nauk; 2010; (5):11-5. PubMed ID: 20614515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipopolysaccharides from atherosclerosis-associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells.
    Triantafilou M; Gamper FG; Lepper PM; Mouratis MA; Schumann C; Harokopakis E; Schifferle RE; Hajishengallis G; Triantafilou K
    Cell Microbiol; 2007 Aug; 9(8):2030-9. PubMed ID: 17419716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting bacterial endotoxin: two sides of a coin.
    Bosshart H; Heinzelmann M
    Ann N Y Acad Sci; 2007 Jan; 1096():1-17. PubMed ID: 17405910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Shared pathogenesis of infectious and cardiovascular diseases--year 2005's view].
    Kunes P; Mand'ák J; Lonský V; Palicka V
    Cas Lek Cesk; 2005; 144(9):592-5; discussion 596. PubMed ID: 16193936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque.
    Carnevale R; Nocella C; Petrozza V; Cammisotto V; Pacini L; Sorrentino V; Martinelli O; Irace L; Sciarretta S; Frati G; Pastori D; Violi F
    Sci Rep; 2018 Feb; 8(1):3598. PubMed ID: 29483584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation.
    Lin FY; Chen YH; Lin YW; Tsai JS; Chen JW; Wang HJ; Chen YL; Li CY; Lin SJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2622-9. PubMed ID: 16990552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase-11 non-canonical inflammasome: a critical sensor of intracellular lipopolysaccharide in macrophage-mediated inflammatory responses.
    Yi YS
    Immunology; 2017 Oct; 152(2):207-217. PubMed ID: 28695629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparison between SARS-CoV-2 and Gram-Negative Bacteria-Induced Hyperinflammation and Sepsis.
    Brandenburg K; Ferrer-Espada R; Martinez-de-Tejada G; Nehls C; Fukuoka S; Mauss K; Weindl G; Garidel P
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of local lipopolysaccharide administration on the expression of Toll-like receptor 4 and pro-inflammatory cytokines in uterus and oviduct of rabbit does.
    Menchetti L; Barbato O; Filipescu IE; Traina G; Leonardi L; Polisca A; Troisi A; Guelfi G; Piro F; Brecchia G
    Theriogenology; 2018 Feb; 107():162-174. PubMed ID: 29161657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways.
    Lin FY; Chen YH; Tasi JS; Chen JW; Yang TL; Wang HJ; Li CY; Chen YL; Lin SJ
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2630-7. PubMed ID: 17008589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques.
    Habib A; Polavarapu R; Karmali V; Guo L; Van Dam R; Cheng Q; Akahori H; Saeed O; Nakano M; Pachura K; Hong CC; Shin E; Kolodgie F; Virmani R; Finn AV
    Atherosclerosis; 2015 Aug; 241(2):692-700. PubMed ID: 26125411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental TLR4 inhibition improves intestinal microcirculation in endotoxemic rats.
    Zhou J; Soltow M; Zimmermann K; Pavlovic D; Johnston B; Lehmann C
    Microvasc Res; 2015 Sep; 101():33-7. PubMed ID: 26116862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin inhibits inflammation and promotes atherosclerotic plaque stability via PI3K-Akt pathway activation.
    Yan H; Ma Y; Li Y; Zheng X; Lv P; Zhang Y; Li J; Ma M; Zhang L; Li C; Zhang R; Gao F; Wang H; Tao L
    Immunol Lett; 2016 Feb; 170():7-14. PubMed ID: 26681144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious agents, inflammation, and growth factors: how do they interact in the progression or stabilization of mild human atherosclerotic lesions?
    Góis J; Higuchi M; Reis M; Diament J; Sousa J; Ramires J; Oliveira S
    Ann Vasc Surg; 2006 Sep; 20(5):638-45. PubMed ID: 16983590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period.
    Harju K; Ojaniemi M; Rounioja S; Glumoff V; Paananen R; Vuolteenaho R; Hallman M
    Pediatr Res; 2005 May; 57(5 Pt 1):644-8. PubMed ID: 15718365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant protein-D attenuates the lipopolysaccharide-induced inflammation in human intestinal cells overexpressing toll-like receptor 4.
    Saka R; Wakimoto T; Nishiumi F; Sasaki T; Nose S; Fukuzawa M; Oue T; Yanagihara I; Okuyama H
    Pediatr Surg Int; 2016 Jan; 32(1):59-63. PubMed ID: 26510735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.